DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,036 filers reported holding DANAHER CORPORATION in Q4 2015. The put-call ratio across all filers is 0.70 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $817,052,000 | +8.7% | 10,496,559 | +9.5% | 0.15% | -1.9% |
Q3 2016 | $751,752,000 | -2.0% | 9,589,894 | +26.3% | 0.15% | -8.9% |
Q2 2016 | $766,712,000 | +16.7% | 7,591,208 | +9.6% | 0.17% | +11.2% |
Q1 2016 | $657,272,000 | +5.5% | 6,928,859 | +3.3% | 0.15% | +5.6% |
Q4 2015 | $623,231,000 | +22.1% | 6,710,068 | +12.0% | 0.14% | +9.1% |
Q3 2015 | $510,516,000 | -3.4% | 5,991,272 | -3.0% | 0.13% | +3.9% |
Q2 2015 | $528,703,000 | +0.7% | 6,177,159 | -0.1% | 0.13% | +1.6% |
Q1 2015 | $525,069,000 | -1.9% | 6,184,559 | -0.9% | 0.12% | -5.3% |
Q4 2014 | $535,108,000 | +16.7% | 6,243,237 | +3.4% | 0.13% | +1.5% |
Q3 2014 | $458,580,000 | +1.9% | 6,035,538 | +5.6% | 0.13% | +2.4% |
Q2 2014 | $449,955,000 | +12.2% | 5,715,164 | +6.9% | 0.13% | +6.7% |
Q1 2014 | $400,908,000 | -4.1% | 5,345,436 | -1.3% | 0.12% | -6.3% |
Q4 2013 | $418,184,000 | +16.4% | 5,416,886 | +4.5% | 0.13% | +5.0% |
Q3 2013 | $359,189,000 | +13.2% | 5,181,613 | +3.4% | 0.12% | +4.3% |
Q2 2013 | $317,198,000 | – | 5,011,022 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 241,441 | $70,822,000 | 14.94% |
Defender Capital, LLC. | 143,752 | $42,381,000 | 14.74% |
Third Point | 2,490,000 | $730,392,000 | 9.51% |
Riverstone Advisors, LLC | 63,015 | $18,484,000 | 9.49% |
11 Capital Partners LP | 96,063 | $28,178,000 | 8.99% |
Eos Focused Equity Management, L.P. | 34,026 | $9,981,000 | 8.54% |
CORTLAND ASSOCIATES INC/MO | 187,609 | $55,031,000 | 7.01% |
Mirova US LLC | 1,242,440 | $364,444,000 | 7.00% |
Front Street Capital Management, Inc. | 118,397 | $34,729,000 | 6.47% |
Alphinity Investment Management Pty Ltd | 909,181 | $266,690,000 | 6.21% |